GM&C Life Sciences Fund
Enderby, United Kingdom
34
1M
31
3.78
16
0.09
- Stages of investment
- Areas of investment
Summary
In 2015 was created GM&C Life Sciences Fund, which is appeared as VC. The fund was located in Europe if to be more exact in United Kingdom. The main office of represented VC is situated in the Alderley Edge.
Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United Kingdom. Among the various public portfolio startups of the fund, we may underline AMR Centre, SurgaColl, Proveca The fund has no exact preference in a number of founders of portfolio startups. We can highlight the next thriving fund investment areas, such as Medical, Therapeutics.
The standard case for the fund is to invest in rounds with 2-3 partakers. Despite the GM&C Life Sciences Fund, startups are often financed by Wren Capital, The North West Fund, SBRI Healthcare. The meaningful sponsors for the fund in investment in the same round are UK Innovation & Science Seed Fund, Deepbridge Capital, Catapult Ventures. In the next rounds fund is usually obtained by EASME - EU Executive Agency for SMEs, 24 Haymarket, SciTech.
The top activity for fund was in 2016. Speaking about the real fund results, this VC is 53 percentage points more often commits exit comparing to other organizations. The fund is constantly included in 7-12 deals per year. The common things for fund are deals in the range of 1 - 5 millions dollars.
Investor highlights
- Stage focus
Discover reliable insights
Find relevant VC investors, identify key contacts and secure funding opportunities.
Investments analytics
Analytics
- Total investments
- 34
- Lead investments
- 16
- Rounds per year
- 3.78
- Follow on index
- 0.09
- Investments by industry
- Health Care (21)
- Biotechnology (20)
- Medical (15)
- Pharmaceutical (13)
- Life Science (8) Show 23 more
- Investments by region
-
- United Kingdom (31)
- Ireland (1)
- Germany (1)
- Italy (1)
- Peak activity year
- 2018
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 8
- Avg. valuation at time of investment
- 364K
- Group Appearance index
- 0.76
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Monument Therapeutics | 01 Jul 2021 | Biotechnology, Health Care, Pharmaceutical | Seed | 3M | Cambridgeshire, Cambridge, United Kingdom |
| Morphic Therapeutic | 30 Jun 2016 | Biotechnology, Health Care, Medical, Therapeutics | Early Stage Venture | 51M | United States, Massachusetts |
| Pronec | 01 Jan 2016 | Biotechnology, Pharmaceutical, Therapeutics | Seed | 68K | United Kingdom, England |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.